> European pharma co. Novartis made in 2012 revenues of $19.7bn in Europe vs $18.6bn in the US (and a total of $56.7bn). Novartis invested 21% of sales into R&D

> European pharma co. Novartis made in 2012 revenues of $19.7bn in Europe vs $18.6bn in the US (and a total of $56.7bn). Novartis invested 21% of sales into R&D. > U.S. pharma company Pfeizer, total revenues of $59bn in 2012, U.S. was $27bn and international $36bn. Pfeizer invested $7.9bn in R&D (c. 13% of revenues). Do you know what fraction of those revenue figures are profit? It is entirely possible that the companies could have different profit margins in different areas.